chr11-61955892-G-A
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PM1PM5PP5_Very_Strong
The NM_004183.4(BEST1):c.422G>A(p.Arg141His) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000286 in 1,550,476 control chromosomes in the GnomAD database, including 1 homozygotes. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R141S) has been classified as Pathogenic.
Frequency
Consequence
NM_004183.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 12 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
BEST1 | NM_004183.4 | c.422G>A | p.Arg141His | missense_variant | 4/11 | ENST00000378043.9 | NP_004174.1 | |
LOC107984334 | XR_001748245.2 | n.2802C>T | non_coding_transcript_exon_variant | 2/2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
BEST1 | ENST00000378043.9 | c.422G>A | p.Arg141His | missense_variant | 4/11 | 1 | NM_004183.4 | ENSP00000367282 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000315 AC: 48AN: 152252Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000521 AC: 78AN: 149610Hom.: 0 AF XY: 0.000491 AC XY: 39AN XY: 79498
GnomAD4 exome AF: 0.000283 AC: 395AN: 1398106Hom.: 1 Cov.: 37 AF XY: 0.000273 AC XY: 188AN XY: 689626
GnomAD4 genome AF: 0.000315 AC: 48AN: 152370Hom.: 0 Cov.: 33 AF XY: 0.000416 AC XY: 31AN XY: 74508
ClinVar
Submissions by phenotype
not provided Pathogenic:7Other:1
Pathogenic, no assertion criteria provided | clinical testing | Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center | - | - - |
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Aug 20, 2015 | The R141H variant in the BEST1 gene has been reported previously in association with Best macular dystrophy (Kramer et al., 2000). This variant was not observed at any significant frequency in either the NHLBI Exome Sequencing Project or the 1000 Genomes Project. The R141H substitution occurs at a position that is conserved across species. Functional in vitro studies have demonstrated that the R141H protein is mislocalized, prematurely degraded, and has significantly reduced chloride conductance relative to the wild-type protein (Davidson et al., 2011; Johnson et al., 2014). We interpret the R141H variant as a pathogenic variant. - |
Pathogenic, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Jun 12, 2014 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Apr 01, 2023 | BEST1: PM3:Very Strong, PM2, PM5, PP4, PS3:Supporting - |
Pathogenic, no assertion criteria provided | clinical testing | Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+ | - | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 01, 2023 | This sequence change replaces arginine, which is basic and polar, with histidine, which is basic and polar, at codon 141 of the BEST1 protein (p.Arg141His). This variant is present in population databases (rs121918284, gnomAD 0.3%), and has an allele count higher than expected for a pathogenic variant. This missense change has been observed in individual(s) with autosomal recessive BEST-related disorders (PMID: 16754206, 21809908, 23290749, 26333019). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 2740). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt BEST1 protein function with a positive predictive value of 95%. Experimental studies have shown that this missense change affects BEST1 function (PMID: 18179881, 21330666, 26200502, 27519691). For these reasons, this variant has been classified as Pathogenic. - |
not provided, no classification provided | literature only | Retina International | - | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Institute of Medical Genetics and Applied Genomics, University Hospital Tübingen | Oct 23, 2020 | - - |
Autosomal recessive bestrophinopathy Pathogenic:3
Pathogenic, no assertion criteria provided | phenotyping only | Laboratorio de Imunogenetica e Histocompatibilidade, Universidade Federal do Parana | Jan 25, 2015 | The variant was found together with c.400C>G. Both are believed are causative of Bestrophinopathy autosomal recessive (BAR). - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Institute of Medical Molecular Genetics, University of Zurich | Jan 30, 2021 | - - |
Pathogenic, no assertion criteria provided | literature only | OMIM | Jun 01, 2011 | - - |
Vitelliform macular dystrophy 2 Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Jun 01, 2011 | - - |
BEST1-related disorder Pathogenic:1
Pathogenic, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Aug 08, 2024 | The BEST1 c.422G>A variant is predicted to result in the amino acid substitution p.Arg141His. This variant has been reported in the compound heterozygous state and segregates in several families with BEST-related disorders (Krämer et al. 2000. PubMed ID: 10854112; Burgess et al. 2008. PubMed ID: 18179881; Borman et al. 2011. PubMed ID: 21825197). Functional studies suggested that this variant causes mislocalization and misfolding of the protein and reduced channel activity (Davidson et al. 2011. PubMed ID: 21330666). The amino acid residue p.Arg141 of the BEST1 protein has been highly conserved during evolution. This variant is reported in 0.33% of alleles in individuals of European (Finnish) descent in gnomAD. This variant is interpreted as pathogenic. - |
Retinal dystrophy Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Blueprint Genetics | Aug 15, 2019 | - - |
Stargardt disease Pathogenic:1
Pathogenic, no assertion criteria provided | research | Department of Clinical Genetics, Copenhagen University Hospital, Rigshospitalet | Apr 01, 2018 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at